AVITA Medical (RCEL) Gains from Sales and Divestitures (2021 - 2025)
AVITA Medical (RCEL) reported Gains from Sales and Divestitures of $109180.0 for Q4 2025, down 26.49% on a YoY basis from $148532.0 in Q4 2024, and little changed quarter-over-quarter from $109180.0 in Q3 2025.
AVITA Medical (RCEL) Gains from Sales and Divestitures (2021 - 2025) Analysis & Trends
AVITA Medical has reported Gains from Sales and Divestitures for 5 years, with the latest figure at $109180.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Sales and Divestitures fell 26.49% year-over-year to $109180.0; the trailing twelve-month figure through Dec 2025 stood at $109180.0 (down 26.49% YoY), and the FY2025 full-year result was $109180.0, down 26.49% from the prior year.
- Gains from Sales and Divestitures for Q4 2025 stood at $109180.0, roughly flat from $109180.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $235059.0 in Q4 2023, with the low at $14608.0 in Q1 2025.
- Historically, Gains from Sales and Divestitures has averaged $106847.9 across 5 years, with a median of $105034.0 in 2022.
- The largest YoY upside for Gains from Sales and Divestitures was 265.28% in 2022 against a maximum downside of 61.26% in 2022.
- AVITA Medical's Gains from Sales and Divestitures stood at $28754.0 in 2021, then soared by 361.04% to $132568.0 in 2022, then surged by 77.31% to $235059.0 in 2023, then plunged by 36.81% to $148532.0 in 2024, then declined by 26.49% to $109180.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $109180.0 (Q4 2025), $109180.0 (Q3 2025), and $76724.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | AVITA Medical | 109.91 Mn | 91.73 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 109,180.00 |
| Dec 31, 2025 | 109,180.00 |
| Sep 30, 2025 | 109,180.00 |
| Sep 30, 2025 | 109,180.00 |
| Jun 30, 2025 | 76,724.00 |
| Jun 30, 2025 | 76,724.00 |
| Mar 31, 2025 | 14,608.00 |
| Mar 31, 2025 | 14,608.00 |
| Dec 31, 2024 | 148,532.00 |
| Dec 31, 2024 | 148,532.00 |
| Sep 30, 2024 | 137,774.00 |
| Sep 30, 2024 | 137,774.00 |
| Jun 30, 2024 | 53,918.00 |
| Jun 30, 2024 | 53,918.00 |
| Dec 31, 2023 | 235,059.00 |
| Dec 31, 2023 | 235,059.00 |
| Sep 30, 2023 | 178,508.00 |
| Sep 30, 2023 | 178,508.00 |
| Jun 30, 2023 | 92,650.00 |
| Jun 30, 2023 | 92,650.00 |